Artículos por temáticas

Socioeconomic disparities in clinical trials on Alzheimer's disease: a systematic review

Canevelli M, Bruno G, Vico C, Zaccaria V, Lacorte E, Iavicoli I, Vanacore N, Cesari M.

Eur J Neurol. 2018 Apr;25(4):626-e43. doi: 10.1111/ene.13587. Epub 2018 Feb 26.

While I Still Remember: 30 Years of Alzheimer's Disease Research

Shea TB.

J Alzheimers Dis. 2018;62(3):1049-1057. doi: 10.3233/JAD-170724.

Study partners: essential collaborators in discovering treatments for Alzheimer's disease

Largent EA, Karlawish J, Grill JD.

Alzheimers Res Ther. 2018 Sep 27;10(1):101. doi: 10.1186/s13195-018-0425-4.

Memorcise and Alzheimer's disease

Loprinzi PD, Frith E, Ponce P.

Phys Sportsmed. 2018 May;46(2):145-154. doi: 10.1080/00913847.2018.1445932. Epub 2018 Mar 9.

Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials

Drygalski K, Fereniec E, Koryciński K, Chomentowski A, Kiełczewska A, Odrzygóźdź C, Modzelewska B.

Exp Gerontol. 2018 Nov;113:36-47. doi: 10.1016/j.exger.2018.09.019. Epub 2018 Sep 25.

Amylin in Alzheimer's disease: Pathological peptide or potential treatment?

Mietlicki-Baase EG.

Neuropharmacology. 2018 Jul 1;136(Pt B):287-297. doi: 10.1016/j.neuropharm.2017.12.016. Epub 2017 Dec 9.

Copper-64: a real theranostic agent

Gutfilen B, Souza SA, Valentini G.

Drug Des Devel Ther. 2018 Oct 2;12:3235-3245. doi: 10.2147/DDDT.S170879. eCollection 2018.

Collapse in the elderly: rivastigmine-induced heart block and a literature review of the pharmacology of acetylcholinesterase inhibitors used in Alzheimer's disease

Alonge O, Iqbal FM, Cifonelli E.

BMJ Case Rep. 2018 Apr 17;2018:bcr2018224597. doi: 10.1136/bcr-2018-224597.

Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease

Devanand DP.

Curr Neurol Neurosci Rep. 2018 Jul 14;18(9):55. doi: 10.1007/s11910-018-0863-1.

Fornical Closed-Loop Stimulation for Alzheimer's Disease

Senova S, Chaillet A, Lozano AM.

Trends Neurosci. 2018 Jul;41(7):418-428. doi: 10.1016/j.tins.2018.03.015. Epub 2018 May 4.

A Review on the Relationship between Tocotrienol and Alzheimer Disease

Chin KY, Tay SS.

Nutrients. 2018 Jul 9;10(7):881. doi: 10.3390/nu10070881.

Alzheimer's Disease: Advances in Drug Development

Piton M, Hirtz C, Desmetz C, Milhau J, Lajoix AD, Bennys K, Lehmann S, Gabelle A.

J Alzheimers Dis. 2018;65(1):3-13. doi: 10.3233/JAD-180145.

Alzheimer-Demenz – die kognitiven «Enhancer» haben kaum einen positiven Effekt auf den weiteren Verlauf

Steurer J.

Praxis (Bern 1994). 2018;107(6):335-336. doi: 10.1024/1661-8157/a002919.

Recent advances in the neurobiology and neuropharmacology of Alzheimer's disease

Kumar K, Kumar A, Keegan RM, Deshmukh R.

Biomed Pharmacother. 2018 Feb;98:297-307. doi: 10.1016/j.biopha.2017.12.053. Epub 2017 Dec 27.

Review of the advances in treatment for Alzheimer disease: Strategies for combating β-amyloid protein

Folch J, Ettcheto M, Petrov D, Abad S, Pedrós I, Marin M, Olloquequi J, Camins A.

Neurologia (Engl Ed). 2018 Jan-Feb;33(1):47-58. doi: 10.1016/j.nrl.2015.03.012. Epub 2015 May 11.